As of 2025-12-24, the Relative Valuation of Homology Medicines Inc (FIXX) is (922.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on Relative Valuation is -3857.2%.
The range of the Relative Valuation is (656.49) - (1,257.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 14.8x | 10.0x |
| Forward P/E multiples | 7.7x - 15.7x | 11.7x |
| Fair Price | (656.49) - (1,257.01) | (922.40) |
| Upside | -2774.1% - -5220.2% | -3857.2% |
| Date | P/E |